Recent Updates
Recently added Catalysts
AMN

Amy C. Chang Vice President, Investor Relations 866.861.3229 AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2012 RESULTS Reports quarterly revenue of $248 million, up 12% year-over-year Diluted EPS from c

Key Takeaway: Contact: Amy C. Chang Vice President, Investor Relations 866.861.3229 AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2012 RESULTS Reports quarterly revenue of $248 million, up 12% year-over-year Diluted EPS from continuing operations of $0.15 vs. $0.04 i

Full Press Release Details

Contact:
Amy C. Chang
Vice President, Investor Relations
866.861.3229
AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2012 RESULTS
Reports quarterly revenue of $248 million, up 12% year-over-year
Diluted EPS from continuing operations of $0.15 vs. $0.04 in prior year
SAN DIEGO (February 21, 2013) AMN Healthcare Services, Inc. (NYSE: AHS), healthcare s innovator in workforce solutions and staffing
services, today announced fourth quarter 2012 financial results which exceeded the Company s guidance for both revenue and adjusted EBITDA. Fourth quarter and full year financial highlights are as follows:
Dollars in millions, except per share amounts.*
Q4 2012 % Chg Q4 2011 % Chg Q3 2012 Full Year 2012 % Chg Full Year 2011
Revenue $ 247.8 12 % 2 % $ 954.0 7 %
Gross profit $ 70.6 12 % 2 % $ 270.4 8 %
Net income $ 7.1 321 % 21 % $ 16.3 225 %
Diluted EPS $ 0.15 275 % 25 % $ 0.35 218 %
Adjusted EBITDA** $ 19.2 22 % 2 % $ 73.7 15 %
Adjusted diluted EPS** $ 0.15 275 % 25 % $ 0.47 194 %
AMN Healthcare made tremendous strides in executing on our long-term strategy during
2012. The investments we made to develop successful, innovative workforce solutions, coupled with the strong execution by our teams, have created significant differentiation and value for our clients, said Susan R. Salka, President and Chief
Executive Officer of AMN Healthcare. We expect 2013 to be another year of steady growth, improved profitability and solid cash flows. Further growth in MSP and other workforce solutions is expected and we will continue to be at the forefront
of innovating and delivering quality, economically beneficial solutions and staffing services to our clients as they navigate through the transformational trends in healthcare.
Full Year 2012 Results
Full year consolidated revenue was $954
million, an increase of 7% from prior year. Nurse and Allied Healthcare Staffing segment revenue was $654 million, a year-over-year increase of 15%. The Travel Nurse business contributed the greatest growth with a 22% revenue increase over prior
year. Locum Tenens Staffing segment revenue was $261 million, a year-over-year decrease of 6%. Physician Permanent Placement Services segment revenue was flat with prior year at $39 million, and up 9% without the impact of deferred revenue
accounting changes implemented in 2011.
Full year gross margin was 28.3% as compared to 28.1% for prior year. The
year-over-year improvement was due primarily to an increase in the Locum Tenens Staffing segment gross margin of 210 basis points.
Full year SG&A expenses were $203 million, representing 21.3% of revenue as compared to
22.0% for the prior year. The improvement was due primarily to improved SG&A leverage and the absence of integration-related expenses, partially offset by increased spending in support of revenue growth and strategic initiatives to enhance
candidate recruitment, workforce solutions, and technology infrastructure.
Full year adjusted EBITDA grew 15% to $74 million.
Adjusted EBITDA margin of 7.7% represented a 50 basis point increase over prior year and was driven by improvement in gross margin and operating leverage. Full year net income from continuing operations was $16 million. Full year net income per
diluted common share from continuing operations was $0.35. Adjusted diluted earnings per share for the full year was $0.47.
As of December 31, 2012, cash and cash equivalents totaled $6 million. Full year cash flow from operations was $61 million, which
enabled debt payments of $50 million throughout the year. The Company ended the year with total debt outstanding, net of discount, of $158 million, with a leverage ratio of 2.4 to 1. Capital expenditures during the year were $5 million.
Fourth Quarter 2012 Results
For the fourth quarter of 2012, consolidated revenue was $248 million, an increase of 12% from the same quarter last year and 2% sequentially. Fourth quarter revenue for the Nurse and Allied Healthcare
Staffing segment was $175 million, up 18% from the same quarter last year and 5% sequentially. Locum Tenens Staffing segment revenue in the fourth quarter was $63 million, a decrease of 3% from the same quarter last year and 7% sequentially. Fourth
quarter Physician Permanent Placement Services segment revenue was $10 million, an increase of 8% from the same quarter last year and 1% sequentially.
Fourth quarter gross margin of 28.5% was higher by 20 basis points than the same quarter last year and flat sequentially. The increase was due primarily to the gross margin improvement in the Locum Tenens
Staffing segment over prior year.
SG&A expenses for the fourth quarter were $53 million, representing 21.4% of revenue,
compared to 22.1% of revenue in the same quarter last year and 21.5% of revenue in the prior quarter. The improvement from the prior year was due to improved operating leverage.
Fourth quarter adjusted EBITDA grew 22% year-over-year to $19 million. Adjusted EBITDA
margin of 7.8% represented a 70 basis point increase over prior year and was driven by improvement in gross margin and operating leverage. Fourth quarter net income from continuing operations was $7 million. Fourth quarter net income per diluted
common share from continuing operations and adjusted diluted earnings per share were $0.15.
Fourth quarter cash flow from
operations was $18 million and capital expenditures were $2 million. The Company made $12 million of voluntary debt prepayments during the fourth quarter.
Business Trends and Outlook
The Company expects first quarter
consolidated revenue to be between $246 million and $250 million, representing year-over-year revenue growth of 9% to 10%. This reflects two fewer calendar days in the quarter, which primarily has an impact on our Nurse Staffing businesses. Gross
margin is expected to be 28.0% to 28.5%. SG&A expenses as a percentage of revenue are expected to be 21.0% to 21.5%. Adjusted EBITDA margin is expected to be 7.5% to 8.0%.
About AMN Healthcare
AMN Healthcare is the innovator in healthcare
workforce solutions and staffing services to healthcare facilities across the nation. AMN Healthcare s workforce solutions - including managed services programs, recruitment process outsourcing and consulting services - enable providers to
successfully reduce complexity, increase efficiency and improve patient outcomes within the rapidly evolving healthcare environment. The Company provides unparalleled access to the largest network of quality clinicians and physicians through its
innovative recruitment strategies and breadth of career opportunities. Clients include acute-care hospitals, government facilities, community health centers and clinics, physician practice groups and many other healthcare settings. For more
information, visit http://www.amnhealthcare.com.
Conference Call on February 21, 2013
AMN Healthcare Services, Inc. s fourth quarter and full year 2012 conference call will be held on Thursday, February 21, 2013,
at 5:00 p.m. Eastern Time. A live webcast of the call can be accessed through AMN Healthcare s website at http://amnhealthcare.investorroom.com/presentations. Please log in at least 10 minutes prior to the conference call in order to download
the applicable audio software. Interested parties may participate live via telephone by dialing (800) 230-1092 in the U.S. or (612) 234-9960 internationally. Following the conclusion of the call, a replay of the webcast will be available
at the Company s website. A telephonic replay of the call will also be available at 7:30 p.m. Eastern Time on February 21, 2013, and can be accessed until 11:59 p.m. Eastern Time on March 7, 2013, by calling (800) 475-6701 in the
U.S. or (320) 365-3844 internationally, with access code 279563.
This earnings release contains certain non-GAAP financial information, which the Company provides as additional information, and not as an alternative, to the Company s consolidated financial
statements presented in accordance with GAAP. These non-GAAP financial measures include (1) segment operating income, (2) adjusted EBITDA, (3) adjusted EBITDA margin, and (4) adjusted EPS. The Company provides such non-GAAP
financial measures because management believes that they are useful both to management and investors as a supplement, and not as a substitute, when evaluating the Company s operating performance. Additionally, management believes that segment
operating income, adjusted EBITDA and adjusted EBITDA margin serve as industry-wide financial measures, and it uses segment operating income and adjusted EBITDA for making financial decisions and allocating resources. The non-GAAP measures in this
release are not in accordance with, or an alternative to GAAP, and may be different from non-GAAP measures, or may be calculated differently than other similarly title captioned non-GAAP measures, reported by other companies. They should not be used
in isolation to evaluate the Company s performance. A reconciliation of non-GAAP measures identified in this release, along with further detail about the use and limitations of certain of these non-GAAP measures, may be found below in the table
entitled Supplemental Financial and Operating Data under the caption entitled Reconciliation of Non-GAAP Items or on the Company s website at http://amnhealthcare.investorroom.com/financialreports. Additionally, from time to
time, additional information regarding non-GAAP financial measures, including pro forma measures, may be made available on the Company s website.
Forward-Looking Statements
This press release contains
forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include expectations regarding 2013
first quarter revenue, gross margin, SG&A, and adjusted EBITDA margin. The Company based these forward-looking statements on its current expectations, estimates and projections about future events and the industry in which it operates using
information currently available to it. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Forward-looking statements are identified by words such as believe,
anticipate, expect, intend, plan, will, may, estimates, variations of such words and other similar expressions. In addition, any statements that refer to
expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Factors that could cause actual results to differ from those implied by the forward-looking statements contained in this press
release are set forth in the Company s Annual Report on Form 10-K for the year ended December 31, 2011 and its other periodic reports as well as its current and other reports filed with the Securities and Exchange Commission. Be advised
that developments subsequent to this press release are likely to cause these statements to become outdated with the passage of time.
AMN Healthcare Services, Inc.
Condensed Consolidated Statements of Comprehensive Income (Loss)
(in thousands, except per share amounts)
Three Months Ended Twelve Months Ended
December 31, September 30, December 31,
2012 2011 2012 2012 2011
Revenue $ 247,841 $ 222,053 $ 243,912 $ 953,951 $ 887,466
Cost of revenue 177,214 159,268 174,329 683,554 638,147
Gross profit 70,627 62,785 69,583 270,397 249,319
28.5 % 28.3 % 28.5 % 28.3 % 28.1 %
Operating expenses:
Selling, general and administrative 53,049 48,963 52,375 202,904 195,348
21.4 % 22.1 % 21.5 % 21.3 % 22.0 %
Depreciation and amortization 3,469 3,845 3,435 14,151 16,324
Total operating expenses 56,518 52,808 55,810 217,055 211,672
Income from operations 14,109 9,977 13,773 53,342 37,647
Interest expense, net (including loss on debt extinguishment of $9,815 for the year ended December 31, 2012) 3,208 5,620 3,688 26,019 23,727
Income from continuing operations before income taxes 10,901 4,357 10,085 27,323 13,920
Income tax expense 3,818 2,673 4,227 11,010 8,904
Income from continuing operations 7,083 1,684 5,858 16,313 5,016
Income (loss) from discontinued operations, net of tax 0 (4,119 ) 0 823 (31,281 )
Net income (loss) $ 7,083 $ (2,435 ) $ 5,858 $ 17,136 $ (26,265 )
Basic income (loss) per common share from:
Continuing operations $ 0.16 $ 0.04 $ 0.13 $ 0.36 $ 0.12
Discontinued operations 0.00 (0.10 ) 0.00 0.02 (0.78 )
Net income (loss) $ 0.16 $ (0.06 ) $ 0.13 $ 0.38 $ (0.66 )
Diluted income (loss) per common share from:
Continuing operations $ 0.15 $ 0.04 $ 0.12 $ 0.35 $ 0.11
Discontinued operations 0.00 (0.09 ) 0.00 0.02 (0.68 )
Net income (loss) $ 0.15 $ (0.05 ) $ 0.12 $ 0.37 $ (0.57 )
Weighted average common shares outstanding:
Basic 44,270 40,440 40,850 41,632 39,913
Diluted 47,296 46,034 46,897 46,709 45,951
Other comprehensive income (loss) (5 ) 18 (55 ) (70 ) 48
Comprehensive income (loss) $ 7,078 $ (2,417 ) $ 5,803 $ 17,066 $ (26,217 )
AMN Healthcare Services, Inc.
Supplemental Financial and Operating Data
(dollars in thousands, except per share and operating data)
Three Months Ended Twelve Months Ended
December 31, September 30, December 31,
2012 2011 2012 2012 2011
Revenue
Nurse and allied healthcare staffing $ 174,997 $ 148,136 $ 166,331 $ 653,829 $ 570,677
Locum tenens staffing 62,739 64,553 67,591 261,431 277,919
Physician permanent placement services 10,105 9,364 9,990 38,691 38,870
$ 247,841 $ 222,053 $ 243,912 $ 953,951 $ 887,466
Reconciliation of Non-GAAP Items:
Segment operating income(1)
Nurse and allied healthcare staffing $ 21,601 $ 18,050 $ 18,785 $ 75,907 $ 62,786
Locum tenens staffing 4,808 3,930 6,298 21,613 21,689
Physician permanent placement services 2,071 2,164 2,201 7,868 10,634
28,480 24,144 27,284 105,388 95,109
Unallocated corporate overhead 9,256 8,351 8,507 31,674 31,089
Adjusted EBITDA(2) 19,224 15,793 18,777 73,714 64,020
Adjusted EBITDA margin(3) 7.8 % 7.1 % 7.7 % 7.7 % 7.2 %
Depreciation and amortization 3,469 3,845 3,435 14,151 16,324
Stock-based compensation 1,646 1,713 1,569 6,221 7,098
Acquisition related costs 0 258 0 0 2,951
Interest expense, net 3,208 5,620 3,688 26,019 23,727
Income from continuing operations before income taxes 10,901 4,357 10,085 27,323 13,920
Income tax expense 3,818 2,673 4,227 11,010 8,904
Net income from continuing operations 7,083 1,684 5,858 16,313 5,016
Net income (loss) from discontinued operations 0 (4,119 ) 0 823 (31,281 )
Net income (loss) $ 7,083 $ (2,435 ) $ 5,858 $ 17,136 $ (26,265 )
GAAP based diluted net income (loss) per share (EPS) $ 0.15 $ (0.05 ) $ 0.12 $ 0.37 $ (0.57 )
Adjustments:
Acquisition related costs 0.00 0.00 0.00 0.00 0.04
Debt refinancing 0.00 0.00 0.00 0.12 0.01
Discontinued operations 0.00 0.09 0.00 (0.02 ) 0.68
Adjusted diluted EPS(4) $ 0.15 $ 0.04 $ 0.12 $ 0.47 $ 0.16
Three Months Ended Twelve Months Ended
December 31, September 30, December 31,
2012 2011 2012 2012 2011
Gross Margin
Nurse and allied healthcare staffing 26.6 % 27.4 % 26.5 % 26.5 % 26.8 %
Locum tenens staffing 28.0 % 25.5 % 28.4 % 27.9 % 25.8 %
Physician permanent placement services 65.2 % 61.7 % 64.1 % 62.3 % 63.0 %
Operating Data:
Nurse and allied healthcare staffing
Average travelers on assignment(5) 6,075 5,317 5,884 5,748 5,208
Revenue per traveler per day(6) $ 313.11 $ 302.84 $ 307.26 $ 310.79 $ 300.21
Gross profit per traveler per day(6) $ 83.17 $ 82.91 $ 81.27 $ 82.47 $ 80.55
Locum tenens staffing
Days filled(7) 44,377 47,610 45,868 182,987 199,196
Revenue per day filled(7) $ 1,413.77 $ 1,355.87 $ 1,473.60 $ 1,428.69 $ 1,395.20
Gross profit per day filled(7) $ 395.50 $ 345.50 $ 418.33 $ 397.92 $ 360.05
As of December 31 As of September 30,
2012 2011 2012
Leverage ratio (8) 2.4 3.3 2.6
AMN Healthcare Services, Inc.
Condensed Consolidated Balance Sheets
(dollars in thousands)
December 31, September 30, December 31,
2012 2012 2011
Assets
Current assets:
Cash and cash equivalents $ 5,681 $ 3,823 $ 3,962
Accounts receivable, net 142,510 141,881 146,654
Accounts receivable, subcontractor 18,467 19,686 22,497
Deferred income taxes, net 18,123 11,685 19,335
Prepaid and other current assets 18,963 16,575 12,715
Assets held for sale 0 0 7,310
Total current assets 203,744 193,650 212,473
Restricted cash, cash equivalents and investments 18,861 18,917 18,244
Fixed assets, net 14,815 14,968 16,863
Deposits and other assets 19,732 21,391 21,152
Goodwill 123,324 123,324 123,324
Intangible assets, net 136,910 138,523 143,575
Total assets $ 517,386 $ 510,773 $ 535,631
Liabilities and stockholders equity
Current liabilities:
Accounts payable and accrued expenses 52,619 43,564 49,809
Accrued compensation and benefits 49,443 49,246 43,649
Revolving credit facility 0 0 3,000
Current portion of notes payable 0 12,000 28,125
Other current liabilities 7,463 10,736 13,983
Liabilities related to assets held for sale 0 0 1,486
Total current liabilities 109,525 115,546 140,052
Notes payable, less current portion and discount 158,178 157,996 174,198
Other long-term liabilities 67,572 64,026 61,646
Total liabilities 335,275 337,568 375,896
Preferred stock 0 22,631 24,076
Stockholders equity 182,111 150,574 135,659
Total liabilities and stockholders equity $ 517,386 $ 510,773 $ 535,631
AMN Healthcare Services, Inc.
Condensed Consolidated Statements of Cash Flows
(dollars in thousands)
Three Months Ended Twelve Months Ended
December 31, September 30, December 31,
2012 2011 2012 2012 2011
Net cash provided by operating activities $ 18,450 $ 6,513 $ 11,512 $ 60,512 $ 19,312
Net cash provided by (used in) investing activities (1,257 ) (1,142 ) (2,103 ) 2,961 (1,981 )
Net cash used in financing activities (15,330 ) (6,070 ) (21,029 ) (61,684 ) (15,300 )
Effect of exchange rates on cash (5 ) 18 (55 ) (70 ) 48
Net increase (decrease) in cash and cash equivalents 1,858 (681 ) (11,675 ) 1,719 2,079
Cash and cash equivalents at beginning of period 3,823 4,643 15,498 3,962 1,883
Cash and cash equivalents at end of period $ 5,681 $ 3,962 $ 3,823 $ 5,681 $ 3,962
Last updated: Feb 21, 2013